390 related articles for article (PubMed ID: 15256450)
1. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
2. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
[TBL] [Abstract][Full Text] [Related]
3. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain.
Kuratomi Y; Nomizu M; Nielsen PK; Tanaka K; Song SY; Kleinman HK; Yamada Y
Exp Cell Res; 1999 Jun; 249(2):386-95. PubMed ID: 10366438
[TBL] [Abstract][Full Text] [Related]
4. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
5. Identification of a heparin binding site and the biological activities of the laminin alpha1 chain carboxy-terminal globular domain.
Yoshida I; Tashiro K; Monji A; Nagata I; Hayashi Y; Mitsuyama Y; Tashiro N
J Cell Physiol; 1999 Apr; 179(1):18-28. PubMed ID: 10082128
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of SIKVAV retro and retro-enantio analogues on tumor metastatic events.
Almiñana N; Grau-Oliete MR; Reig F; Rivera-Fillat MP
Peptides; 2004 Feb; 25(2):251-9. PubMed ID: 15063006
[TBL] [Abstract][Full Text] [Related]
7. Identification of homologous biologically active sites on the N-terminal domain of laminin alpha chains.
Nomizu M; Yokoyama F; Suzuki N; Okazaki I; Nishi N; Ponce ML; Kleinman HK; Yamamoto Y; Nakagawa S; Mayumi T
Biochemistry; 2001 Dec; 40(50):15310-7. PubMed ID: 11735413
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
Yamamura K; Kibbey MC; Kleinman HK
Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
[TBL] [Abstract][Full Text] [Related]
9. Identification of cell binding sites in the laminin alpha5-chain G domain.
Makino M; Okazaki I; Kasai S; Nishi N; Bougaeva M; Weeks BS; Otaka A; Nielsen PK; Yamada Y; Nomizu M
Exp Cell Res; 2002 Jul; 277(1):95-106. PubMed ID: 12061820
[TBL] [Abstract][Full Text] [Related]
10. Cell adhesive sequences in mouse laminin beta1 chain.
Nomizu M; Kuratomi Y; Ponce ML; Song SY; Miyoshi K; Otaka A; Powell SK; Hoffman MP; Kleinman HK; Yamada Y
Arch Biochem Biophys; 2000 Jun; 378(2):311-20. PubMed ID: 10860548
[TBL] [Abstract][Full Text] [Related]
11. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
12. Tumor invasion-inhibiting factor 2: primary structure and inhibitory effect on invasion in vitro and pulmonary metastasis of tumor cells.
Isoai A; Giga-Hama Y; Shinkai K; Mukai M; Akedo H; Kumagai H
Cancer Res; 1992 Mar; 52(6):1422-6. PubMed ID: 1311631
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
[TBL] [Abstract][Full Text] [Related]
14. An IKLLI-containing peptide derived from the laminin alpha1 chain mediating heparin-binding, cell adhesion, neurite outgrowth and proliferation, represents a binding site for integrin alpha3beta1 and heparan sulphate proteoglycan.
Tashiro K; Monji A; Yoshida I; Hayashi Y; Matsuda K; Tashiro N; Mitsuyama Y
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):119-26. PubMed ID: 10229666
[TBL] [Abstract][Full Text] [Related]
15. Laminin α5-derived peptides modulate the properties of metastatic breast tumour cells.
Kusuma N; Anderson RL; Pouliot N
Clin Exp Metastasis; 2011 Dec; 28(8):909-21. PubMed ID: 21938437
[TBL] [Abstract][Full Text] [Related]
16. Syndecan binding sites in the laminin alpha1 chain G domain.
Suzuki N; Ichikawa N; Kasai S; Yamada M; Nishi N; Morioka H; Yamashita H; Kitagawa Y; Utani A; Hoffman MP; Nomizu M
Biochemistry; 2003 Nov; 42(43):12625-33. PubMed ID: 14580209
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional peptides derived from homologous loop regions in the laminin alpha chain LG4 modules interact with both alpha 2 beta 1 integrin and syndecan-2.
Yokoyama F; Suzuki N; Kadoya Y; Utani A; Nakatsuka H; Nishi N; Haruki M; Kleinman HK; Nomizu M
Biochemistry; 2005 Jul; 44(28):9581-9. PubMed ID: 16008343
[TBL] [Abstract][Full Text] [Related]
18. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells.
Fukuda MN; Ohyama C; Lowitz K; Matsuo O; Pasqualini R; Ruoslahti E; Fukuda M
Cancer Res; 2000 Jan; 60(2):450-6. PubMed ID: 10667600
[TBL] [Abstract][Full Text] [Related]
19. Identification of an active site on the laminin alpha4 chain globular domain that binds to alphavbeta3 integrin and promotes angiogenesis.
Lian J; Dai X; Li X; He F
Biochem Biophys Res Commun; 2006 Aug; 347(1):248-53. PubMed ID: 16824487
[TBL] [Abstract][Full Text] [Related]
20. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis.
Xu XM; Chen Y; Chen J; Yang S; Gao F; Underhill CB; Creswell K; Zhang L
Cancer Res; 2003 Sep; 63(18):5685-90. PubMed ID: 14522884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
